$3.45
0.01[0.29%]
At close: Apr 19
$3.45
0[0.00%]
After Hours: 4:15PM EDT
Prelude Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Prelude Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/06/2024 | AM | PRLD | Q1 | -$0.58 | — | — | — | $0.00 | — | — | — | Get Alert |
05/03/2024 | AM | PRLD | Q4 | -$0.60 | -$0.48 | — | — | $0.00 | — | — | — | Get Alert |
11/01/2023 | AM | PRLD | Q3 | -$0.63 | -$0.58 | -$0.45 | 22.41% | $0.00 | — | $0.00 | — | Get Alert |
08/03/2023 | AM | PRLD | Q2 | -$0.58 | -$0.63 | -$0.54 | 14.29% | $0.00 | — | $0.00 | — | Get Alert |
05/08/2023 | AM | PRLD | Q1 | -$0.63 | -$0.68 | -$0.58 | 14.71% | $0.00 | — | $0.00 | — | Get Alert |
03/15/2023 | AM | PRLD | Q4 | -$0.71 | -$0.63 | -$0.60 | 4.76% | $0.00 | — | $0.00 | — | Get Alert |
11/14/2022 | AM | PRLD | Q3 | -$0.66 | -$0.64 | -$0.63 | 1.56% | $0.00 | — | $0.00 | — | Get Alert |
08/09/2022 | AM | PRLD | Q2 | -$0.58 | -$0.65 | -$0.58 | 10.77% | $0.00 | — | $0.00 | — | Get Alert |
05/10/2022 | AM | PRLD | Q1 | -$0.47 | -$0.65 | -$0.63 | 3.08% | $0.00 | — | $0.00 | — | Get Alert |
03/16/2022 | AM | PRLD | Q4 | -$0.45 | -$0.68 | -$0.71 | -4.41% | $0.00 | — | $0.00 | — | Get Alert |
11/12/2021 | AM | PRLD | Q3 | -$5.25 | -$0.62 | -$0.66 | -6.45% | $0.00 | — | $0.00 | — | Get Alert |
08/12/2021 | AM | PRLD | Q2 | -$5.50 | -$0.49 | -$0.58 | -18.37% | $0.00 | — | $0.00 | — | Get Alert |
05/11/2021 | AM | PRLD | Q1 | — | -$0.46 | -$0.47 | -2.17% | — | — | $0.00 | — | Get Alert |
03/16/2021 | AM | PRLD | Q4 | — | — | -$0.45 | — | — | — | $0.00 | — | Get Alert |
11/10/2020 | AM | PRLD | Q3 | -$3.93 | — | -$5.25 | — | $0.00 | — | $0.00 | — | Get Alert |
Prelude Therapeutics (PRLD) is scheduled to report earnings on May 6, 2024. The last reported earnings were for reported on November 1, 2023 for Q3.
The Actual EPS was $-0.45, which beat the estimate of $-0.58.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.